Damage-Associated Molecular Patterns in Inflammatory Diseases

Jong Seong Roh1, Dong Hyun Sohn1

  • 1Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan 50612, Korea.

Immune Network
|September 6, 2018
PubMed

Insights

Damage-associated molecular patterns (DAMPs) are released from damaged cells and activate immune responses. This review explores their pathogenic role in diseases like arthritis, Alzheimer's, and cancer, highlighting DAMPs as potential biomarkers and therapeutic targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pathology

Background:

  • Damage-associated molecular patterns (DAMPs) are endogenous molecules released from stressed or necrotic cells.
  • DAMPs interact with pattern recognition receptors (PRRs), activating innate immune responses.
  • While crucial for host defense, DAMPs can also drive pathological inflammation.

Purpose of the Study:

  • To review the current understanding of DAMPs' roles in various inflammatory diseases.
  • To explore the involvement of specific DAMPs like HMGB1, S100 proteins, and HSPs.
  • To discuss the potential of DAMPs as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review of recent research on DAMPs and inflammatory diseases.
  • Analysis of studies investigating HMGB1, S100 proteins, and HSPs.
  • Examination of evidence linking DAMPs to specific conditions such as rheumatoid arthritis, lupus, osteoarthritis, atherosclerosis, Alzheimer's, Parkinson's, and cancer.

Main Results:

  • DAMPs are implicated in the pathogenesis of numerous inflammatory and neurodegenerative diseases.
  • Elevated levels of specific DAMPs (HMGB1, S100, HSPs) are observed in affected patients.
  • DAMPs contribute to chronic inflammation and tissue damage in conditions like arthritis and atherosclerosis.
  • DAMPs are increasingly recognized for their role in neuroinflammation in Alzheimer's and Parkinson's disease.
  • DAMPs are also implicated in cancer development and progression.

Conclusions:

  • DAMPs play a significant dual role in immunity, contributing to both defense and disease.
  • Targeting DAMPs offers a promising therapeutic strategy for a range of inflammatory and chronic diseases.
  • DAMPs hold potential as valuable biomarkers for early diagnosis and disease monitoring.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
632
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
755
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.8K